[1] GHIASI M, KULKARNI MT. Is endometriosis more common and more severe than it was 30 years ago?[J]. J Minim Invasive Gynecol, 2020, 27(2): 452. doi: 10.1016/j.jmig.2019.11.018
[2] ALBORZI S, ZAHIRI SOROURI Z, ASKARI E, et al. The success of various endometrioma treatments in infertility: a systematic review and meta-analysis of prospective studies[J]. Reprod Med Biol, 2019, 18(4): 312. doi: 10.1002/rmb2.12286
[3] KHAN KN, FUJISHITA A, HIRAKI K, et al. Bacterial contamination hypothesis: a new concept in endometriosis[J]. Reprod Med Biol, 2018, 17(2): 125. doi: 10.1002/rmb2.12083
[4] BORRELLI GM, ABRAO MS. Can chemokines be used as biomarkers for endometriosis? A systematic review[J]. Hum Reprod, 2014, 29(2): 253. doi: 10.1093/humrep/det401
[5] 林巧, 丁少杰, 竺天虹, 等. 凝血和炎症因子在中重度卵巢子宫内膜异位症发病中的作用及临床诊断的意义[J]. 中华妇产科杂志, 2018, 53(3): 167. doi: 10.3760/cma.j.issn.0529-567x.2018.03.005
[6] BULLÓN P, NAVARRO JM. Inflammasome as a key pathogenic mechanism in endometriosis[J]. Curr Drug Targets, 2017, 18(9): 997.
[7] CHEN L, WANG X, SHU J, et al. Diagnostic value of serum D-dimer, CA125, and neutrophil-to-lymphocyte ratio in differentiating ovarian cancer and endometriosis[J]. Int J Gynaecol Obstet, 2019, 147(2): 212. doi: 10.1002/ijgo.12949
[8] YANG H, ZHU L, WANG S, et al. Noninvasive diagnosis of moderate to severe endometriosis: the platelet-lymphocyte ratio cannot be a neoadjuvant biomarker for serum cancer antigen 125[J]. J Minim Invasive Gynecol, 2015, 22(3): 373. doi: 10.1016/j.jmig.2013.06.003
[9] Revised American Society for Reproductive Medicine classification of endometriosis: 1996[J]. Fertil Steril, 1997, 67(5): 817.
[10] PAN L, YU Y, YU M, et al. Expression of flTF and asTF splice variants in various cell strains and tissues[J]. Mol Med Rep, 2019, 19(3): 2077.
[11] PALARETI G, LEGNANI C, COSMI B, et al. Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study[J]. Int J Lab Hematol, 2016, 38(1): 42. doi: 10.1111/ijlh.12426
[12] HAN K, LU Q, ZHU WJ, et al. Correlations of degree of coronary artery stenosis with blood lipid, CRP, Hcy, GGT, SCD36 and fibrinogen levels in elderly patients with coronary heart disease[J]. Eur Rev Med Pharmacol Sci, 2019, 23(21): 9582.
[13] GAO XY, ZHOU BY, ZHANG MZ, et al. Association between fibrinogen level and the severity of coronary stenosis in 418 male patients with myocardial infarction younger than 35 years old[J]. Oncotarget, 2017, 8(46): 81361. doi: 10.18632/oncotarget.18578
[14] KVASKOFF M, MU F, TERRY KL, et al. Endometriosis: a high-risk population for major chronic diseases?[J]. Hum Reprod Update, 2015, 21(4): 500. doi: 10.1093/humupd/dmv013
[15] ZHANG T, ZHANG C, CHEN RX, et al. Correlation between coronary artery lesion quantitative score and OSAHS and relative risk factors[J]. Eur Rev Med Pharmacol Sci, 2018, 22(5): 1415.
[16] SUN M, DENG Z, SHI F, et al. Rebamipide-loaded chitosan nanoparticles accelerate prostatic wound healing by inhibiting M1 macrophage-mediated inflammation via the NF-κB signaling pathway[J]. Biomater Sci, 2020, 8(3): 912. doi: 10.1039/C9BM01512D
[17] ZHANG J. Protective effect of ginkgolic acid in attenuating LDL induced inflammation human peripheral blood mononuclear cells altering the NF-κB signaling pathway[J]. Front Pharmacol, 2019, 10: 1241. doi: 10.3389/fphar.2019.01241